ischemic diseases

dynaCERT Inc.
Latest Comments

Hemostemix adds depth and strength to its scientific bench on the road to commercialization

Since we last covered Hemostemix where they released the promising results of their retrospective study of heart disease and the […]

Hemostemix posts promising clinical trial results from heart failure and limb ischemia treatment

Heart failure (HF) is a growing epidemic in the United States, with an estimated 6 million people affected. HF is […]